Characteristic |
HIV |
HCV |
Type of virus and how
transmitted |
Bloodborne. Also present in semen, vaginal
fluid and breast milk |
Bloodborne. Also may be present in
semen and vaginal fluid |
Whether sexual
transmission occurs |
Sexual transmission common |
Sexual transmission less common,
especially among heterosexual couples,
but does occur among HIV-positive gay
men |
Risk of mother-to-child
transmission (MTCT) |
Risk of mother-to-child transmission
can be dramatically reduced with use of
antiretroviral therapy |
Risk of MTCT of HCV is higher if you
are HIV-positive. In the UK, women with
coinfection are recommnded to have an
elective C-section to lower the risk. |
Risk from breastmilk |
Breast feeding can transmit HIV |
Risk of HCV transmission from breast feeding is considered very low (unless
mother's nipples are cracked or
bleeding) |
Whether lifelong |
Yes (at time of writing) |
Not always chronic (can be cleared/
cured) |
Risk of reinfection |
Reinfection with HIV happens. In many
cases it may not have serious implications
unless the new virus is drug resistant (cases
of reinfection with drug-resistant HIV have
been reported, but no one is sure how often
this happens). HIV reinfection is the subject
of current research. |
Reinfection with hepatitis C occurs,
and being reinfected with a different
genotype may make it more difficult
to treat. For example, if someone with
HCV genotype 2 is reinfected with HCV
genotype 1.
Clearing the virus with a natural immune
response or with treatment doesn't
protect you from reinfection in the future. |
How infectious outside the
body |
HIV is a fragile virus. Dies quickly when
outside of the human body |
HCV is a tougher virus. Can live for
days outside of the human body. |
Is treatment always
needed? |
Treatment is not always necessary, but it is
needed by the majority of people at some
time. Less than 5% people still have not
needed to start treatment 15 years after
infection. |
Treatment is not always necessary.
Some people clear the virus naturallly
and some people do not get symptoms
even in chronic infection. |
Speed of progression |
People can live with HIV for many years
without symptoms (average 5-8 without
treatment). |
People can live with HCV for many
years without symptoms (average over
10-15 for people with coinfection). |
Effect of treatment on viral
load |
Levels of HIV in the blood can be
suppressed by treatment. |
HCV can be virtually eradicated from the
bloodstream if treatment is successful. |
Duration of treatment |
Treatment can be lifelong. |
Treatment usually lasts for a year or less. |
Impact of viral load on how
fast the disease progressed |
Viral load is linked to disease progression. |
Viral load is linked to treatment
response, but not disease severity or
progression. |
Choice of treatment |
More than 20 drugs available, that
specifically target the virus. |
Currently, standard of care is
combination therapy with pegylated
interferon plus ribavirin, two drugs that
do not specifically target the virus. |
Research pipeline |
Drugs from new classes and existing
classes are currently in development. |
Drugs from new and existing classes are
currently in development. |